Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for PLRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 165.17M
December 31, 2025 181.20M
September 30, 2025 200.31M
June 30, 2025 220.08M
March 31, 2025 257.16M
December 31, 2024 304.08M
September 30, 2024 345.82M
June 30, 2024 392.68M
March 31, 2024 437.33M
December 31, 2023 473.58M
September 30, 2023 503.05M
June 30, 2023 533.06M
March 31, 2023 561.92M
Date Value
December 31, 2022 313.34M
September 30, 2022 336.99M
June 30, 2022 147.79M
March 31, 2022 173.79M
December 31, 2021 199.06M
September 30, 2021 220.44M
June 30, 2021 243.98M
March 31, 2021 264.17M
December 31, 2020 283.06M
September 30, 2020 300.35M
June 30, 2020 315.82M
March 31, 2020 173.56M
December 31, 2019 109.98M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. 68.14M
CorMedix, Inc. 437.05M
Eloxx Pharmaceuticals, Inc. -7.584M
Cannabis Global, Inc. -4.772M
BioStem Technologies, Inc. 31.87M

Shareholders Equity (Quarterly) Related Metrics